{
    "id": "280c139f-c3a2-46e4-b990-ce3808166e86",
    "indications": {
        "text": "gabapentin indicated : management postherpetic neuralgia adults adjunctive therapy treatment partial onset seizures , without secondary generalization , adults pediatric patients 3 years older epilepsy",
        "doid_entities": [
            {
                "text": "epilepsy (DOID:1826)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_1826"
            }
        ],
        "orphanet_entities": []
    },
    "contraindications": {
        "text": "postherpetic neuralgia ( 2.1 ) dose titrated needed dose 1800 mg/day day 1 : single 300 mg dose day 2 : 600 mg/day ( i.e . , 300 mg two times day ) day 3 : 900 mg/day ( i.e . , 300 mg three times day ) epilepsy partial onset seizures ( 2.2 ) patients 12 years age older : starting dose 300 mg three times daily ; may titrated 600 mg three times daily patients 3 11 years age : starting dose range 10 15 mg/kg/day , given three divided doses ; recommended dose patients 3 4 years age 40 mg/kg/day , given three divided doses ; recommended dose patients 5 11 years age 25 35 mg/kg/day , given three divided doses . recommended dose reached upward titration period approximately 3 days dose adjusted patients reduced renal function ( 2.3 , 2.4 )",
        "doid_entities": [
            {
                "text": "epilepsy (DOID:1826)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_1826"
            }
        ],
        "orphanet_entities": []
    },
    "warningsAndPrecautions": "gabapentin tablets , usp supplied follows : 600 mg tablets : white white elliptical film coated tablets `` g/6 `` debossed one side scored sides , available : bottles 100 : ndc 67877-428-01 bottles 500 : ndc 67877-428-05 bottles 1000 : ndc 67877-428-10 one carton 100 ( 10 x 10 unit-dose tablets ) : ndc 67877-428-38 800 mg tablets : white white elliptical film coated tablets `` g/8 `` debossed one side scored sides , available : bottles 100 : ndc 67877-429-01 bottles 500 : ndc 67877-429-05 bottles 1000 : ndc 67877-429-10 one carton 100 ( 10 x 10 unit-dose tablets ) : ndc 67877-429-38 store 20\u00ba 25\u00bac ( 68\u00ba 77\u00baf ) ; excursions permitted 15\u00b0 30\u00b0c ( 59\u00b0 86\u00b0f ) [ usp controlled room temperature ] .",
    "adverseReactions": "gabapentin contraindicated patients demonstrated hypersensitivity ingredients .",
    "ingredients": [
        {
            "name": "GABAPENTIN",
            "code": "6CW7F3G59X",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_42797"
        },
        {
            "name": "STARCH, CORN",
            "code": "O8232NY3SJ",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_28017"
        },
        {
            "name": "POLOXAMER 407",
            "code": "TUF2IVW3M2",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32026"
        },
        {
            "name": "TALC",
            "code": "7SEV7J4R1U",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32178"
        },
        {
            "name": "HYDROXYPROPYL CELLULOSE (1600000 WAMW)",
            "code": "RFW2ET671P",
            "drugbank_id": "https://go.drugbank.com/drugs/DB00840"
        },
        {
            "name": "COPOVIDONE K25-31",
            "code": "D9C330MD8B",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_78913"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30",
            "drugbank_id": "https://go.drugbank.com/drugs/DB14077"
        }
    ],
    "organization": "Ascend Laboratories, LLC",
    "name": "Gabapentin",
    "effectiveTime": "20250502",
    "indications_original": "Gabapentin is indicated for:\n                  \n                     Management of postherpetic neuralgia in adults\n                     Adjunctive therapy in the treatment of partial onset seizures, with and without secondary generalization, in adults and pediatric patients 3 years and older with epilepsy",
    "contraindications_original": "Postherpetic Neuralgia ( 2.1 ) o Dose can be titrated up as needed to a dose of 1800 mg/day o Day 1: Single 300 mg dose o Day 2: 600 mg/day (i.e., 300 mg two times a day) o Day 3: 900 mg/day (i.e., 300 mg three times a day) Epilepsy with Partial Onset Seizures ( 2.2 ) Patients 12 years of age and older: starting dose is 300 mg three\u00a0 times daily; may be titrated up to 600 mg three times daily Patients 3 to 11 years of age: starting dose range is 10 to 15 mg/kg/day, given in three divided doses; recommended dose in patients 3 to 4 years of age is 40 mg/kg/day, given in three divided doses; the recommended dose in patients 5 to 11 years of age is 25 to 35 mg/kg/day, given in three divided doses. The recommended dose is reached by upward titration over a period of approximately 3 days Dose should be adjusted in patients with reduced renal function ( 2.3 , 2.4 )",
    "warningsAndPrecautions_original": "Gabapentin tablets, USP are supplied as follows:\n                  \n                  600 mg tablets:\n                  White to off white elliptical film coated tablets with \"G/6\" debossed on one side and scored on both sides, available in:\n                  Bottles of 100: NDC 67877-428-01\n                  Bottles of 500: NDC 67877-428-05\n                  Bottles of 1000: NDC 67877-428-10\n                  One Carton of 100 (10 x 10 Unit-dose Tablets): NDC 67877-428-38\n                  800 mg tablets:\n                  White to off white elliptical film coated tablets with \"G/8\" debossed on one side and scored on both sides, available in:\n                  Bottles of 100: NDC 67877-429-01\n                  Bottles of 500: NDC 67877-429-05\n                  Bottles of 1000: NDC 67877-429-10\n                  One Carton of 100 (10 x 10 Unit-dose Tablets): NDC 67877-429-38\n                  \n                  Store at 20\u00ba to 25\u00baC (68\u00ba to 77\u00baF); excursions permitted to 15\u00b0 to 30\u00b0C (59\u00b0 to 86\u00b0F) [See USP Controlled Room Temperature].",
    "adverseReactions_original": "Gabapentin is contraindicated in patients who have demonstrated hypersensitivity to the drug or its ingredients.",
    "drug": [
        {
            "name": "Gabapentin",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_42797"
        }
    ]
}